Company Snapshot
- Ticker
- COR
- Name
- COR
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 66078840210.000000
- Volume
- 1,416,215
- Avg Volume (3M)
- 1,519,287
COR
COR
Last update recent
340.79
+3.50
(+1.04%)
Market Cap
66078840210.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 321332819000.000000
- EPS
- 8.02
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.66%
- Net Income
- 1554169000.000000
- Net Margin
- 0.48%
- Payout Ratio
- 28.12%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 42.52
- Forward P/E
- None
- P/S
- 0.21
- P/B
- 37.82
- Beta
- None
- Debt / Equity
- 4.38
- Current Ratio
- 0.90
- Return on Equity
- 0.89%
- Return on Assets
- 0.02%
Technicals & Returns
- Distance vs 200 DMA
- 13.94%
- 200 DMA
- 299.09
- Distance vs 50 DMA
- 0.16%
- 50 DMA
- 340.26
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solu Read more
- Name
- COR
- Industry
- Medical - Distribution
- CEO
- Dr. Robert P. Mauch Ph.D., PharmD
- Employees
- 46,000
- IPO Date
- 1995-04-04
- Phone
- 610 727 7000
- Address
- None
- Website
- https://www.amerisourcebergen.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-08-09 • $0.51
Latest News
Curated headlines from premium sources.
Cencora to take majority control of OneOncology to expand cancer services
U.S. drug distributor Cencora said on Monday it will take majority control of cancer care network OneOncology in a deal that values the business at $7.4 billio…
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced it has entered into a definitive agreement to acquire the majority of the outstan…
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
Cencora, Inc. $COR Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System reduced its stake in shares of Cencora, Inc. (NYSE: COR) by 11.0% during the undefined quarter, according to its …
Why Is Cencora (COR) Down 6.3% Since Last Earnings Report?
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
CW Advisors LLC Increases Stake in Cencora, Inc. $COR
CW Advisors LLC raised its position in shares of Cencora, Inc. (NYSE: COR) by 181.0% in the second quarter, according to the company in its most recent filing …